Patents Assigned to Zeenar Enterprises Pty Ltd
  • Liquid crystalline dosage form for administering a statin
    Patent number: 11638698
    Abstract: A composition including an amphiphilic compound capable of self-assembling into liquid crystalline particles and a statin for systemic administration via oral mucosa. A method of lowering blood cholesterol levels in a subject comprising administering the self-assembling liquid crystalline particles and statin via oral mucosa. Preferred dosage forms result in prolonged release of the statin.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: May 2, 2023
    Assignee: Zeenar Enterprises Pty Ltd
    Inventors: Gregory Yu Foo Szto, Tomer Madmon, David Kannar
  • PROCESS FOR PREPARING AN ORAL DISINTEGRATING DOSAGE FORM
    Publication number: 20210145730
    Abstract: An oral disintegrating tablet (ODT) comprising an active ingredient, about 1 to about 20% w/w of at least one amphiphilic compound, about 1 to about 60% w/w of at least one disintegrant and about 0.5 to about 5% w/w of at least one binder, wherein the ODT has hardness of at least about 1 kp and wherein, when the ODT contacts a hydrophilic solvent, the amphiphilic compound self-assembles into liquid crystalline particles.
    Type: Application
    Filed: April 20, 2018
    Publication date: May 20, 2021
    Applicant: Zeenar Enterprises Pty Ltd
    Inventors: Tomer MADMON, David KANNAR
  • Niacin formulation
    Patent number: 10335403
    Abstract: The present invention provides a composition including an amphiphilic compound capable of self-assembling into a liquid crystalline phase; and a niacin compound. In another aspect, the present invention provides a method for the treatment of a disease state comprising administering a therapeutically effective amount of a pharmaceutical composition incorporating that composition.
    Type: Grant
    Filed: September 16, 2018
    Date of Patent: July 2, 2019
    Assignee: ZEENAR ENTERPRISE PTY LTD
    Inventors: Xavier Mulet, Gregory Yu Foo Szto, David Kannar
  • NIACIN FORMULATION
    Publication number: 20190015403
    Abstract: The present invention provides a composition including an amphiphilic compound capable of self-assembling into a liquid crystalline phase; and a niacin compound.
    Type: Application
    Filed: September 16, 2018
    Publication date: January 17, 2019
    Applicant: Zeenar Enterprises Pty Ltd.
    Inventors: Xavier Mulet, Gregory Yu Foo Szto, David Kannar
  • Niacin formulation
    Patent number: 10105358
    Abstract: The present invention provides a composition including an amphiphilic compound capable of self-assembling into a liquid crystalline phase; and a niacin compound. In another aspect, the present invention provides a method for the treatment of a disease state comprising administering a therapeutically effective amount of a pharmaceutical composition incorporating that composition.
    Type: Grant
    Filed: May 9, 2014
    Date of Patent: October 23, 2018
    Assignee: ZEENAR ENTERPRISES PTY LTD
    Inventors: Xavier Mulet, Gregory Yu Foo Szto, David Kannar
  • Niacin Formulation
    Publication number: 20160081996
    Abstract: The present invention provides a composition including an amphiphilic compound capable of self-assembling into a liquid crystalline phase; and a niacin compound.
    Type: Application
    Filed: May 9, 2004
    Publication date: March 24, 2016
    Applicant: Zeenar Enterprises Pty Ltd
    Inventors: Xavier Mulet, Gregory Yu Foo Szto, David Kannar